As of Jul 26, 2024, the CONMED stock's P/E ratio is 26.39. This takes into account the latest EPS of $2.69 and stock price of $71. The PE ratio has decreased by 41% from its last 4 quarters average of 45.1.
The PE ratio of CONMED has averaged 251.21 over the last ten years. The current price-to-earnings ratio of 26.39 is 89% less than the historical average. Analyzing the last ten years, CNMD's PE ratio reached its highest point in the Sep 2020 quarter at 3,933.5, when the price was $78.67 and the EPS was $0.02. The lowest point was recorded in the Mar 2018 quarter, when it reached 24.93 with a price of $63.33 and an EPS of $2.54.
Maximum annual increase: 206.53% in 2020
Maximum annual decrease: -80.48% in 2021
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 52.15 | N/A |
| 2022 | N/A | N/A |
| 2021 | 66.24 | -80.48% |
| 2020 | 339.39 | 206.53% |
| 2019 | 110.72 | 150.05% |
| 2018 | 44.28 | 72.9% |
| 2017 | 25.61 | -69.27% |
| 2016 | 83.34 | 108.09% |
| 2015 | 40.05 | 4.22% |
| 2014 | 38.43 | 17.56% |
CNMD's current PE ratio is under its 3, 5 and 10-year averages.
CNMD's PE ratio is less than its peer stocks SYK and BSX, but it is above JNJ's. CONMED's current PE ratio of 26.39 is less than the average of its peers, which is 39.27.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.55 | $386.7B |
| CNMD CONMED Corp | 26.39 | $2.19B |
| MDT Medtronic plc | 28.41 | $100.91B |
| TFX Teleflex Inc | 35.14 | $10.38B |
| SYK Stryker Corp | 37.48 | $126.35B |
| IART Integra Lifesciences Holdings Corp | 61.63 | $2.48B |
| BSX Boston Scientific Corp | 62.43 | $110.15B |
CNMD's price to earnings ratio is 26.39 as of Jul 26, 2024.
As an average over the last 3 years, CNMD stock has a PE ratio of 53.1.
As an average over the last 5 years, CNMD stock has a PE ratio of 510.17.
Over the last ten years, the Sep 2020 quarter recorded the highest quarterly PE ratio at 3,933.5.
CNMD's price to earnings ratio is currently 89% below its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jul 26, 2024), CONMED's share price is $71. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $2.69. Therefore, CONMED's price to earnings ratio for today is 26.39. PE RATIO(26.39) = STOCK PRICE($71) / TTM EPS($2.69)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.